The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read...
Shares of Novavax popped almost 23% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine candidate showed to be 96.4% effective...
Novavax Covid-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the UK
President Joe Biden told U.S. states on March 11 to make all adults eligible for a coronavirus vaccine by May 1 and urged Americans to stay...
Genentech reported that the company's rheumatoid arthritis drug Actemra failed to hit the primary endpoint in a Covid-19 trial, while Vir and GlaxoSmithKline’s antibody against Covid-19...
Sanofi and Translate Bio havew started a human trial of their mRNA Covid-19 vaccine candidate, the French drugmaker’s second vaccine project, which follows a protein-based shot...
Hot Penny Stocks Trading Higher On Thursday
Asure Software announced better-than-expected 4Q results. Meanwhile, revenues of the cloud-based human capital management (HCM) software solutions provider declined year-over-year, reflecting the negative impact of the...
The Real Reasons Why Millions Of Americans Will Defy COVID Mandates And Vaccines Authored by Brandon Smith via Alt-Market.us, I suspect a large portion of the...
All Vaccines Are Not Created Equal In The Eyes Of The Public As countries continue the push to innoculate their populations against Covid-19, problems with vaccine...
Four articles from The Conversation US archive provide context and analysis on the historic legislation.
The stock market has been pulled aggressively in both directions in 2021, but the moves are relatively tame compared to the wild ride of Vaxart (VXRT)...
Watch Live: President Biden Addresses The Nation (But Won't Do A Press Conference) President Biden will deliver his first prime-time address from the White House tonight...
Hundreds Of Defense Contractor Lobbyists Were Behind New $264BN Nuclear ICBM 'Boondoggle' Authored by Jake Johnson via CommonDreams.org, A new report by the Federation of American Scientists set for...
Topline results from an investigator-initiated trial in Brazil show that treatment with Kintor Pharmaceutical’s proxalutamide cut mortality risk by 92 percent and significantly shortened the median...
The Bank of Canada sees the potential for a pleasant surprise from savings-fuelled household spending, but also that monetary stimulus will continue to be required for...